Our results imply that, at least in glioma cells, LAIR1-induced FAK nuclear translocation has a greater effect on malignant glioma growth than FAK catalytic activity inhibition, emphasizing the importance of assessing LAIR1 expression levels when utilizing FAK inhibitors for cancer treatment. Here, LAIR1 is linked to malignant glioma.